Found 52 resultsAuthor Title Type [ Year]
Filters: Author is Age-Related Eye Disease Study (AREDS) Research Group [Clear All Filters]
“A Simplified Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 18”, Arch Ophthalmol, vol. 123, pp. 1570-1574, 2005.,
“Antioxidant supplementation prevents the oxidation of blood plasma cysteine/cystine redox status in elderly subjects”, 2004.,
“Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study (AREDS) - A propensity score approach”, 2004.,
“Clinical features and nature course of drusenoid pigment epithelial detachments in age-related macular degeneration”, 2004.,
“Dietary carotenoids and risk for age-related macular degeneration in the Age-Related Eye Disease Study”, 2004.,
“Effect of Antioxidant Supplementation on Blood Plasma Thiol Redox Status in AREDS Participants with Early to Late ARMD”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO) 27th Annual Macula Society Meeting, Ft. Lauderdale, FL and Las Vegas, NV, 2004.,
“Estimated reates of progression to advanced AMD and vision loss by baseline maculopathy status: Results from the Age-Related Eye Disease Study”, 2004.,
“Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD”, 2004.,
“AREDS Update II: Mortality and Nutritional Risk Factors”, in American Academy of Ophthalmology Meeting, Anaheim, CA, 2003.
“Dietary intake studies of antioxidants or zinc versus high-dose supplements in a randomized clinical trial; associations with cognitive impairment”, 2003.,
“Dietary Intake Studies, Randomized Trials of Nutritional Supplements, and Resulting Public Impact”, presented at the 2003, London, UK, 2003.,
“Dietary Omega-3 long-chain polyunsaturated fatty acids and risk for age-related macular degeneration”, 2003.,
“Do Antioxidants or Zinc Affect Cognitive Function in an Older Population?”, in The Fifth International Conference on Dietary Assessment Methods, Chiang Rai, Thailand, 2003.,
“Do they stay or do they go: characterizing long-term study follow-up in the Age-Related Eye Disease Study”, 2003.,
“Mortality in the Age-Related Eye Disease Study: Associations with Lens Opacity and Cataract Surgery”, 2003.,
“Not simply a matter of faulty memory: obstacles to implementing cognitive function ancillary studies in clinical trials with other primary outcomes”, 2003.,
“Quality Control Issues in a Genetic Repository - The Age-Related Eye Disease Study Experience”, in Annual Meeting, Society for Clinical Trials, London, UK, 2003.,
“A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Age-Related Eye Disease Study Report No. 8”, Archives of Ophthalmology, vol. 119, no. 10, pp. 1417-1436, 2001.
“Risk Factors Associated with Age-Related Nuclear and Cortical Cataract - A Case-Control Study in the Age-Related Eye Disease Study. AREDS Report No. 5”, Ophthalmology, vol. 108, pp. 1400-1408, 2001.
“The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants-Age-Related Eye Disease Study Report No. 2”, J Nutrition, vol. 130, p. 1516S-19S, 2000.
“Baseline Nutritional Status of AREDS Participants, Poster Presentation by AREDS Participants”, Experimental Biology, 1999.